Updated on October 17, 2024 at 2:33 PM. The FDA has approved a supplemental new drug application (sNDA) for sodium oxybate (Lumryz; Avadel Pharmaceuticals) for… Continue a ler »FDA Approves Sodium Oxybate to Treat Cataplexy or EDS in Pediatric Narcolepsy Patients